Ainos, Inc. Common Stock
Symbol: AIMD (NASDAQ)
3.56
▲ (3.19%) 0.110
Company Description:
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
Key Stats
- Today's Open: $3.522
- Today's High: $3.56
- Today's Low: $3.522
- Today's Volume: 0
- Yesterday Close: $3.45
- Yesterday High: $3.56
- Yesterday Low: $3.31
- Yesterday Volume: 108.37K
- Last Min Volume: 0
- Last Min High: $3.56
- Last Min Low: $3.555
- Last Min VWAP: $0
Company Profile
- Name: Ainos, Inc. Common Stock
- Website: https://www.ainos.com
- Listed Date: 1996-08-08
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001014763
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $16.07M
- Round Lot: 100
- Outstanding Shares: 4.66M
- Asset Type: CS
RECENT FILINGS FOR AIMD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 8-K | View |
| 2025-09-05 | 424B5 | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-07 | 4 | View |
| 2025-08-07 | 8-K | View |
| 2025-07-31 | 8-K | View |
| 2025-07-21 | 4 | View |
| 2025-07-16 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-27 | 4 | View |
| 2025-06-27 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-25 | 4 | View |
| 2025-06-24 | 8-K | View |
| 2025-06-23 | 4 | View |
| 2025-05-29 | DEF 14C | View |
| 2025-05-19 | PRE 14C | View |
| 2025-05-14 | 10-Q | View |
| 2025-05-12 | 8-K | View |
Latest News on AIMD